ePrints

Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia

Lookup NU author(s): Dr Peter GallagherORCiD, Dr Stuart Watson, Margaret Smith, Emeritus Professor Nicol Ferrier, Professor Allan Young

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Background: It has been suggested that hypercortisolemia may cause or exacerbate both neurocognitive impairment and symptoms in schizophrenia. We hypothesized that antiglucocorticoid treatments, particularly glucocorticoid receptor (GR) antagonists, would improve neurocognitive functioning and clinical symptoms in this disorder. Method: Twenty patients with schizophrenia were treated with 600 mg/day of the GR-antagonist mifepristone (RU-486) or placebo for 1 week in a double-blind, crossover design. Neurocognitive function was evaluated at baseline and 2 weeks after each treatment. Neuroendocrine profiling was preformed at these times and also immediately after each treatment. Symptoms were evaluated weekly. Results: Mifepristone administration resulted in a temporary two- to threefold increase in plasma cortisol levels (p < .0001). No sigtnificant effects were observed on any measure of neurocognitive function, including the primary outcome measures of spatial working memory and declarative memory. Minor changes in symptoms occurred in both arms of the study and were indicative of a general improvement over time, irrespective of treatment. Conclusions: In contrast to our earlier report of positive effects in bipolar disorder, these data suggest that the GR-antagonist mifepristone has no effect on neurocognitive function or symptoms in this group of patients with schizophrenia. Future studies in schizophrenia should examine patients with demonstrable hypothalmic-pituitary-adrenal axis dysfunction.

Publication metadata

Author(s): Gallagher P, Watson S, Smith MS, Ferrier IN, Young AH

Publication type: Article

Publication status: Published

Journal: Biological Psychiatry

Year: 2005

Volume: 57

Issue: 2

Pages: 155-161

ISSN (print): 0006-3223

ISSN (electronic): 1873-2402

Publisher: Elsevier Inc.

URL: http://dx.doi.org/10.1016/j.biopsych.2004.10.017

DOI: 10.1016/j.biopsych.2004.10.017

Altmetrics

Share